Tag Oxford University

(ایمرا نیوزآن لائن) ہمیں اکثر کسی بھی جگہ وقت سے پہلے یا وقت پر پہنچنے کا کہا جاتا ہے اور ہم اکثر ایسا ہی کرتے ہیں لیکن ایک تحقیق سے ایسی بات سامنے آئی ہے جو کہ تاخیر سے اور وقت پر پہنچنے والے دونوں طرح کے لوگوں کو حیران کرسکتی ہے۔

آکسفورڈ یونیورسٹی کی حالیہ تحقیق سے اس بات کا انکشاف ہوا ہے کہ وہ لوگ جو ہر جگہ ہمیشہ تاخیر سے پہنچتے ہیں وہ لمبی زندگی جینےکے ساتھ ساتھ خوش مزاج بھی ہوتے ہیں۔ماہرین کا کہنا ہے کہ وہ لوگ جو کہیں بھی دیر سے پہنچنے کے عادی ہوتے ہیں ان کا بلڈ پریشر بھی معتدل ہوتا ہے جب کہ ان میں امراض قلب کے امکانات بھی بے حد کم پائے جاتے ہیں۔

ماہرین کا کہنا ہےکہ بنیادی طور پر یہ لوگ وقت پر پہنچنے والے لوگوں کے مقابلے میں زیادہ آرام دہ اور پرسکون ہوتے ہیں اور یہی وجہ ہے کہ ان لوگوں کی دل کی صحت اچھی ہوتی ہے جب کہ ان میں فالج کا خطرہ کم ہوتا ہے اور ایسے لوگوں میں ڈپریشن کے امکانات بھی بے حد کم ہوتے ہیں۔تحقیق کے مطابق زندگی میں پُر امید ہونا انسان کی صحت کو بہتر کرتا ہے جبکہ اس کا تعلق بہتر کار کردگی اور کامیابی سے بھی ہے۔

LONDON: Nobel Prize Laureate Malala Yousafzai’s portrait has been unveiled at the National Portrait Gallery in London.

Malala’s father, Ziauddin Yousafzai, took to Twitter to announce the news.

Yousafzai shared that the portrait of Malala by Shirin Nishat has a poem inscribed on it which is written by Pushto poet Rahmat Shah Sayel.

“We are grateful to the artist for creating this wonderful piece of art depicting strength, resilience and courage,” he wrote.

Malala is currently studying at Oxford University and is an advocate for girls’ education.

She was shot by a Taliban gunman in 2012 while sitting in her school bus in Swat Valley.

GENEVA: Prosecutors in Geneva have opened a rape and sexual misconduct investigation against Islamic scholar Tariq Ramadan, who has been detained in France since February on separate rape charges, Swiss media reported Sunday.

The Tribune de Geneve newspaper quoted Henri Della Casa, a spokesperson for the office of Geneva’s prosecutor, as saying that authorities had decided to open a formal criminal inquiry into allegations that Ramadan raped a woman in a Geneva hotel in 2008.

“I confirm the opening of an inquiry,” the paper quoted Della Casa as saying, a key step that indicated the authorities believed the allegations merit further investigation.

The accuser lodged her complaint in April.

“The prosecutors and Geneva police have worked quickly and worked well,” Romain Jordan, the lawyer representing Ramadan’s Swiss accuser, told AFP in an email.

He described the decision to open a criminal inquiry as “a major advance” that “demonstrates the seriousness of the allegations made by our client”.

Ramadan, a Swiss citizen whose grandfather founded Egypt’s Muslim Brotherhood movement, has not yet been interviewed by Swiss prosecutors.

Jordan said that following the opening of a criminal case, Swiss investigators will now have to travel to France to hear Ramadan’s side of the alleged rape.

The 56-year-old scholar, a prominent and controversial figure within Islam, has denied any criminal wrongdoing.

Ramadan, who took leave from his post at Oxford University after the allegations surfaced, has complained that his imprisonment has made it more difficult for him to receive treatment for multiple sclerosis (MS).

Ramadan, a married father of four who is one of European Islam’s best-known figures, is being held in a prison hospital in Fresnes, south of Paris.

On Tuesday, Ramadan will be questioned in the presence of a second accuser, a disabled woman identified as “Christelle” who claims he raped and beat her in a hotel in the southeastern French city of Lyon in 2009.

PESHAWAR:(media92news) The health department’s project to provide free treatment to poor cancer patients in partnership with private organisations has been receiving worldwide recognition, according to sources.
They said that the model of the project was likely to be replicated in the developing countries. Treatment of poor blood cancer patients started by the health department has benefited more than 2,100 people with 88 per cent survival rate at department of medical oncology at Hayatabad Medical Complex, Peshawar.
Prof Abid Jameel, head of the department, will make a presentation at Oxford University, UK on the model adopted by the health department for free treatment of cancer patients.
Model of project likely to be replicated in developing countries
“There has been a heated debate throughout the world about the expensive anti-cancer drugs, procedure and diagnosis. Research is being conducted to look into ways and means to ensure treatment of the patients, who cannot afford high cost of medication,” Prof Abid told .media92news
“We would be making a presentation at Oxford University, UK on September 9 wherein the model we designed and implemented would be shared with the participants,” he said.
Prof Abid said that health department started the project under the public-private partnership programme with drug manufacturing firm Novartis in 2011 to enable the poor patients to seek treatment for blood cancer.
Under the initiative, the company spent 90 per cent and government spent 10 per cent of the total expenditure incurred on the treatment of the patients, he said.
“The drug manufacturers have been extending this facility to the governments as part of their corporate social responsibility to enable the people to get cure free of cost. The UK Cancer Care Commission has accepted the health department’s model to be presented at the conference for the benefits of other countries, especially the developing ones,” he said.
Prof Abid said that people had accessibility to expensive treatment of cancer due to insurance programmes and huge budgetary allocations for health sector but poor patients were dying of cancer for want of medicines.
He said that the model designed by health department of Khyber Pakhtunkhwa was later replicated in Sindh and Punjab provinces to ensure treatment of poor cancer patients.
“We have also started homework to replicate the same model in Gilgit-Baltistan where people have a lot of difficulties in treatment of the ailment,” he added.
Prof Abid said that currently people of Gilgit-Baltistan visited Peshawar and Islamabad to seek treatment for cancer.
“We have spent about Rs15 billion on the treatment of patients so far. In this, the government’s share was Rs1 billion while the rest came from the drug manufacturer with which we have signed a Memorandum of Understanding,” he added.
He said that recently agreements were signed with other pharmaceutical companies for provision of medicines at discounted rates. “One firm has agreed to a concession of 35 per cent and another to 70 per cent,” he added.